AbbVie 2013 Annual Report Download - page 31

Download and view the complete annual report

Please find page 31 of the 2013 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 176

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Annual Report on Form 10-K contains certain forward looking statements regarding business
strategies, market potential, future financial performance and other matters. The words ‘‘believe,’’
‘‘expect,’’ ‘‘anticipate,’’ ‘‘project’’ and similar expressions, among others, generally identify ‘‘forward
looking statements,’’ which speak only as of the date the statements were made. The matters discussed
in these forward looking statements are subject to risks, uncertainties and other factors that could cause
actual results to differ materially from those projected, anticipated or implied in the forward looking
statements. In particular, information included under Item 1, ‘‘Business,’’ Item 1A, ‘‘Risk Factors,’’ and
Item 7, ‘‘Management’s Discussion and Analysis of Financial Condition and Results of Operations’’
contain forward looking statements. Where, in any forward looking statement, an expectation or belief
as to future results or events is expressed, such expectation or belief is based on the current plans and
expectations of AbbVie management and expressed in good faith and believed to have a reasonable
basis, but there can be no assurance that the expectation or belief will result or be achieved or
accomplished. Factors that could cause actual results or events to differ materially from those
anticipated include the matters described under Item 1A, ‘‘Risk Factors’’ and Item 7, ‘‘Management’s
Discussion and Analysis of Financial Condition and Results of Operations.’’ AbbVie does not
undertake any obligation to update the forward-looking statements included in this Annual Report on
Form 10-K to reflect events or circumstances after the date hereof, unless AbbVie is required by
applicable securities law to do so.
ITEM 1B. UNRESOLVED STAFF COMMENTS
None.
ITEM 2. PROPERTIES
AbbVie’s corporate offices are located at 1 North Waukegan Road, North Chicago,
Illinois 60064-6400. AbbVie’s principal manufacturing plants are in the following locations:
United States Outside the United States
Abbott Park, Illinois* Campoverde di Aprilia, Italy
Barceloneta, Puerto Rico Cork, Ireland
Jayuya, Puerto Rico Ludwigshafen, Germany
North Chicago, Illinois Sligo, Ireland
Worcester, Massachusetts
* Leased property.
In addition to the above, AbbVie has other manufacturing facilities in the United States and
worldwide. AbbVie believes its facilities are suitable and provide adequate production capacity.
In the United States, including Puerto Rico, AbbVie has one distribution center. AbbVie also has
four United States research and development facilities located at: Abbott Park, Illinois; North Chicago,
Illinois; Redwood City, California; and Worcester, Massachusetts. Outside the United States, AbbVie’s
principal research and development facilities are located in Shanghai, China and Ludwigshafen,
Germany.
Except as noted, the principal plants in the United States listed above are owned by AbbVie or
subsidiaries of AbbVie. The remaining manufacturing plants and all other facilities are owned or leased
by AbbVie or subsidiaries of AbbVie.
27